Finance

Lists
ALIF-B:STO
AddLife AB
SEK 184.20
+1.94%
(+3.50) 1D
Oct 23, 4:29:40 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ALIF-B...
Open
SEK 180.90
High
SEK 185.10
Low
SEK 177.50
Mkt. cap
21.71B
Avg. vol.
174.30K
Volume
0.00
52-wk high
SEK 208.40
52-wk low
SEK 130.20
Shares outstanding
117.88M
No. of employees
2K
Open
SEK 180.90
High
SEK 185.10
Low
SEK 177.50
Mkt. cap
21.71B
Avg. vol.
174.30K
Volume
0.00
52-wk high
SEK 208.40
52-wk low
SEK 130.20
Shares outstanding
117.88M
No. of employees
2K
News stories
From web sources and news partners
About AddLife AB
CEO-
Employees2.43K
Founded1906
Headquarters-
SectorHealth care
Websiteadd.life
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.43B
2.73B
2.64B
2.72B
Cost of goods sold
1.52B
1.69B
1.62B
1.65B
Cost of revenue
1.52B
1.69B
1.62B
1.65B
Research and development expenses
14.00M
14.00M
15.00M
15.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
734.00M
820.00M
794.00M
836.00M
Operating expense
743.00M
804.00M
794.00M
838.00M
Total operating expenses
2.26B
2.50B
2.42B
2.48B
Operating income
165.00M
237.00M
229.00M
236.00M
Other non operating income
-2.00M
-4.00M
-2.00M
-
EBT including unusual items
111.00M
343.00M
183.00M
189.00M
EBT excluding unusual items
111.00M
189.00M
183.00M
189.00M
Income tax expense
29.00M
83.00M
55.00M
59.00M
Effective tax rate
26.13%
24.20%
30.05%
31.22%
Other operating expenses
-5.00M
-30.00M
-15.00M
-13.00M
Net income
81.00M
260.00M
127.00M
130.00M
Net profit margin
3.33%
9.51%
4.80%
4.78%
Earnings per share
0.66
1.15
1.04
1.06
Interest and investment income
-
4.00M
-
-
Interest expense
-47.00M
-43.00M
-42.00M
-43.00M
Net interest expenses
-47.00M
-39.00M
-42.00M
-43.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
366.00M
446.00M
423.00M
437.00M
Gain or loss from assets sale
-
-4.00M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps